The global Bispecific Antibody Drug market size was valued at US$ 5.67 billion in 2024 and is projected to reach US$ 12.34 billion by 2030, at a CAGR of 13.8% during the forecast period 2024-2030.
The United States Bispecific Antibody Drug market size was valued at US$ 1.78 billion in 2024 and is projected to reach US$ 3.89 billion by 2030, at a CAGR of 13.9% during the forecast period 2024-2030.
Advanced therapeutic antibodies targeting two different antigens for enhanced treatment efficacy.
Oncology sector drives 58% of demand. Research institutions influence 45% of development. Clinical trials affect 42% of approval. Treatment efficacy shows 40% correlation with adoption. Disease targeting drives 38% of innovation. Regulatory compliance affects 35% of market access.
Report Overview
This report provides a deep insight into the global Bispecific Antibody Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bispecific Antibody Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bispecific Antibody Drug market in any manner.
Global Bispecific Antibody Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Roche
- Amgen
- Sanofi
- Pfizer
- Johnson & Johnson
- AstraZeneca
- Abbvie
- Lindis Biotech
- MacroGenics
- Genmab
- Immunocore Limited
- Xencor
- Merck
- Affimed
- Alphamab
- Akeso
- BeiGene
Market Segmentation (by Type)
Market Segmentation (by Application)
- Cancer
- Haemophilia
- Other Diseases
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Bispecific Antibody Drug Market
- Overview of the regional outlook of the Bispecific Antibody Drug Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bispecific Antibody Drug
1.2 Key Market Segments
1.2.1 Bispecific Antibody Drug Segment by Type
1.2.2 Bispecific Antibody Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bispecific Antibody Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Bispecific Antibody Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bispecific Antibody Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bispecific Antibody Drug Market Competitive Landscape
3.1 Global Bispecific Antibody Drug Sales by Manufacturers (2019-2024)
3.2 Global Bispecific Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bispecific Antibody Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bispecific Antibody Drug Sales Sites, Area Served, Product Type
3.6 Bispecific Antibody Drug Market Competitive Situation and Trends
3.6.1 Bispecific Antibody Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bispecific Antibody Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bispecific Antibody Drug Industry Chain Analysis
4.1 Bispecific Antibody Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bispecific Antibody Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bispecific Antibody Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bispecific Antibody Drug Sales Market Share by Type (2019-2024)
6.3 Global Bispecific Antibody Drug Market Size Market Share by Type (2019-2024)
6.4 Global Bispecific Antibody Drug Price by Type (2019-2024)
7 Bispecific Antibody Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bispecific Antibody Drug Market Sales by Application (2019-2024)
7.3 Global Bispecific Antibody Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Bispecific Antibody Drug Sales Growth Rate by Application (2019-2024)
8 Bispecific Antibody Drug Market Segmentation by Region
8.1 Global Bispecific Antibody Drug Sales by Region
8.1.1 Global Bispecific Antibody Drug Sales by Region
8.1.2 Global Bispecific Antibody Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Bispecific Antibody Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bispecific Antibody Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bispecific Antibody Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bispecific Antibody Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bispecific Antibody Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Bispecific Antibody Drug Basic Information
9.1.2 Roche Bispecific Antibody Drug Product Overview
9.1.3 Roche Bispecific Antibody Drug Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Bispecific Antibody Drug SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Amgen
9.2.1 Amgen Bispecific Antibody Drug Basic Information
9.2.2 Amgen Bispecific Antibody Drug Product Overview
9.2.3 Amgen Bispecific Antibody Drug Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Bispecific Antibody Drug SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 Sanofi
9.3.1 Sanofi Bispecific Antibody Drug Basic Information
9.3.2 Sanofi Bispecific Antibody Drug Product Overview
9.3.3 Sanofi Bispecific Antibody Drug Product Market Performance
9.3.4 Sanofi Bispecific Antibody Drug SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Pfizer
9.4.1 Pfizer Bispecific Antibody Drug Basic Information
9.4.2 Pfizer Bispecific Antibody Drug Product Overview
9.4.3 Pfizer Bispecific Antibody Drug Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Bispecific Antibody Drug Basic Information
9.5.2 Johnson and Johnson Bispecific Antibody Drug Product Overview
9.5.3 Johnson and Johnson Bispecific Antibody Drug Product Market Performance
9.5.4 Johnson and Johnson Business Overview
9.5.5 Johnson and Johnson Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Bispecific Antibody Drug Basic Information
9.6.2 AstraZeneca Bispecific Antibody Drug Product Overview
9.6.3 AstraZeneca Bispecific Antibody Drug Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Abbvie
9.7.1 Abbvie Bispecific Antibody Drug Basic Information
9.7.2 Abbvie Bispecific Antibody Drug Product Overview
9.7.3 Abbvie Bispecific Antibody Drug Product Market Performance
9.7.4 Abbvie Business Overview
9.7.5 Abbvie Recent Developments
9.8 Lindis Biotech
9.8.1 Lindis Biotech Bispecific Antibody Drug Basic Information
9.8.2 Lindis Biotech Bispecific Antibody Drug Product Overview
9.8.3 Lindis Biotech Bispecific Antibody Drug Product Market Performance
9.8.4 Lindis Biotech Business Overview
9.8.5 Lindis Biotech Recent Developments
9.9 MacroGenics
9.9.1 MacroGenics Bispecific Antibody Drug Basic Information
9.9.2 MacroGenics Bispecific Antibody Drug Product Overview
9.9.3 MacroGenics Bispecific Antibody Drug Product Market Performance
9.9.4 MacroGenics Business Overview
9.9.5 MacroGenics Recent Developments
9.10 Genmab
9.10.1 Genmab Bispecific Antibody Drug Basic Information
9.10.2 Genmab Bispecific Antibody Drug Product Overview
9.10.3 Genmab Bispecific Antibody Drug Product Market Performance
9.10.4 Genmab Business Overview
9.10.5 Genmab Recent Developments
9.11 Immunocore Limited
9.11.1 Immunocore Limited Bispecific Antibody Drug Basic Information
9.11.2 Immunocore Limited Bispecific Antibody Drug Product Overview
9.11.3 Immunocore Limited Bispecific Antibody Drug Product Market Performance
9.11.4 Immunocore Limited Business Overview
9.11.5 Immunocore Limited Recent Developments
9.12 Xencor
9.12.1 Xencor Bispecific Antibody Drug Basic Information
9.12.2 Xencor Bispecific Antibody Drug Product Overview
9.12.3 Xencor Bispecific Antibody Drug Product Market Performance
9.12.4 Xencor Business Overview
9.12.5 Xencor Recent Developments
9.13 Merck
9.13.1 Merck Bispecific Antibody Drug Basic Information
9.13.2 Merck Bispecific Antibody Drug Product Overview
9.13.3 Merck Bispecific Antibody Drug Product Market Performance
9.13.4 Merck Business Overview
9.13.5 Merck Recent Developments
9.14 Affimed
9.14.1 Affimed Bispecific Antibody Drug Basic Information
9.14.2 Affimed Bispecific Antibody Drug Product Overview
9.14.3 Affimed Bispecific Antibody Drug Product Market Performance
9.14.4 Affimed Business Overview
9.14.5 Affimed Recent Developments
9.15 Alphamab
9.15.1 Alphamab Bispecific Antibody Drug Basic Information
9.15.2 Alphamab Bispecific Antibody Drug Product Overview
9.15.3 Alphamab Bispecific Antibody Drug Product Market Performance
9.15.4 Alphamab Business Overview
9.15.5 Alphamab Recent Developments
9.16 Akeso
9.16.1 Akeso Bispecific Antibody Drug Basic Information
9.16.2 Akeso Bispecific Antibody Drug Product Overview
9.16.3 Akeso Bispecific Antibody Drug Product Market Performance
9.16.4 Akeso Business Overview
9.16.5 Akeso Recent Developments
9.17 BeiGene
9.17.1 BeiGene Bispecific Antibody Drug Basic Information
9.17.2 BeiGene Bispecific Antibody Drug Product Overview
9.17.3 BeiGene Bispecific Antibody Drug Product Market Performance
9.17.4 BeiGene Business Overview
9.17.5 BeiGene Recent Developments
10 Bispecific Antibody Drug Market Forecast by Region
10.1 Global Bispecific Antibody Drug Market Size Forecast
10.2 Global Bispecific Antibody Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bispecific Antibody Drug Market Size Forecast by Country
10.2.3 Asia Pacific Bispecific Antibody Drug Market Size Forecast by Region
10.2.4 South America Bispecific Antibody Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bispecific Antibody Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Bispecific Antibody Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bispecific Antibody Drug by Type (2025-2030)
11.1.2 Global Bispecific Antibody Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bispecific Antibody Drug by Type (2025-2030)
11.2 Global Bispecific Antibody Drug Market Forecast by Application (2025-2030)
11.2.1 Global Bispecific Antibody Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Bispecific Antibody Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bispecific Antibody Drug Market Size Comparison by Region (M USD)
Table 5. Global Bispecific Antibody Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Bispecific Antibody Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bispecific Antibody Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bispecific Antibody Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2022)
Table 10. Global Market Bispecific Antibody Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bispecific Antibody Drug Sales Sites and Area Served
Table 12. Manufacturers Bispecific Antibody Drug Product Type
Table 13. Global Bispecific Antibody Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bispecific Antibody Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bispecific Antibody Drug Market Challenges
Table 22. Global Bispecific Antibody Drug Sales by Type (Kilotons)
Table 23. Global Bispecific Antibody Drug Market Size by Type (M USD)
Table 24. Global Bispecific Antibody Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Bispecific Antibody Drug Sales Market Share by Type (2019-2024)
Table 26. Global Bispecific Antibody Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Bispecific Antibody Drug Market Size Share by Type (2019-2024)
Table 28. Global Bispecific Antibody Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Bispecific Antibody Drug Sales (Kilotons) by Application
Table 30. Global Bispecific Antibody Drug Market Size by Application
Table 31. Global Bispecific Antibody Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Bispecific Antibody Drug Sales Market Share by Application (2019-2024)
Table 33. Global Bispecific Antibody Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Bispecific Antibody Drug Market Share by Application (2019-2024)
Table 35. Global Bispecific Antibody Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Bispecific Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Bispecific Antibody Drug Sales Market Share by Region (2019-2024)
Table 38. North America Bispecific Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Bispecific Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Bispecific Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Bispecific Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Bispecific Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Bispecific Antibody Drug Basic Information
Table 44. Roche Bispecific Antibody Drug Product Overview
Table 45. Roche Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Bispecific Antibody Drug SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Amgen Bispecific Antibody Drug Basic Information
Table 50. Amgen Bispecific Antibody Drug Product Overview
Table 51. Amgen Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Bispecific Antibody Drug SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. Sanofi Bispecific Antibody Drug Basic Information
Table 56. Sanofi Bispecific Antibody Drug Product Overview
Table 57. Sanofi Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Bispecific Antibody Drug SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Pfizer Bispecific Antibody Drug Basic Information
Table 62. Pfizer Bispecific Antibody Drug Product Overview
Table 63. Pfizer Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Johnson and Johnson Bispecific Antibody Drug Basic Information
Table 67. Johnson and Johnson Bispecific Antibody Drug Product Overview
Table 68. Johnson and Johnson Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Johnson and Johnson Business Overview
Table 70. Johnson and Johnson Recent Developments
Table 71. AstraZeneca Bispecific Antibody Drug Basic Information
Table 72. AstraZeneca Bispecific Antibody Drug Product Overview
Table 73. AstraZeneca Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Abbvie Bispecific Antibody Drug Basic Information
Table 77. Abbvie Bispecific Antibody Drug Product Overview
Table 78. Abbvie Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Abbvie Business Overview
Table 80. Abbvie Recent Developments
Table 81. Lindis Biotech Bispecific Antibody Drug Basic Information
Table 82. Lindis Biotech Bispecific Antibody Drug Product Overview
Table 83. Lindis Biotech Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lindis Biotech Business Overview
Table 85. Lindis Biotech Recent Developments
Table 86. MacroGenics Bispecific Antibody Drug Basic Information
Table 87. MacroGenics Bispecific Antibody Drug Product Overview
Table 88. MacroGenics Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. MacroGenics Business Overview
Table 90. MacroGenics Recent Developments
Table 91. Genmab Bispecific Antibody Drug Basic Information
Table 92. Genmab Bispecific Antibody Drug Product Overview
Table 93. Genmab Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Genmab Business Overview
Table 95. Genmab Recent Developments
Table 96. Immunocore Limited Bispecific Antibody Drug Basic Information
Table 97. Immunocore Limited Bispecific Antibody Drug Product Overview
Table 98. Immunocore Limited Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Immunocore Limited Business Overview
Table 100. Immunocore Limited Recent Developments
Table 101. Xencor Bispecific Antibody Drug Basic Information
Table 102. Xencor Bispecific Antibody Drug Product Overview
Table 103. Xencor Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Xencor Business Overview
Table 105. Xencor Recent Developments
Table 106. Merck Bispecific Antibody Drug Basic Information
Table 107. Merck Bispecific Antibody Drug Product Overview
Table 108. Merck Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Merck Business Overview
Table 110. Merck Recent Developments
Table 111. Affimed Bispecific Antibody Drug Basic Information
Table 112. Affimed Bispecific Antibody Drug Product Overview
Table 113. Affimed Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Affimed Business Overview
Table 115. Affimed Recent Developments
Table 116. Alphamab Bispecific Antibody Drug Basic Information
Table 117. Alphamab Bispecific Antibody Drug Product Overview
Table 118. Alphamab Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Alphamab Business Overview
Table 120. Alphamab Recent Developments
Table 121. Akeso Bispecific Antibody Drug Basic Information
Table 122. Akeso Bispecific Antibody Drug Product Overview
Table 123. Akeso Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Akeso Business Overview
Table 125. Akeso Recent Developments
Table 126. BeiGene Bispecific Antibody Drug Basic Information
Table 127. BeiGene Bispecific Antibody Drug Product Overview
Table 128. BeiGene Bispecific Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. BeiGene Business Overview
Table 130. BeiGene Recent Developments
Table 131. Global Bispecific Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Bispecific Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Bispecific Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Bispecific Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Bispecific Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Bispecific Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Bispecific Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Bispecific Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Bispecific Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Bispecific Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Bispecific Antibody Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Bispecific Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Bispecific Antibody Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Bispecific Antibody Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Bispecific Antibody Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Bispecific Antibody Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Bispecific Antibody Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Bispecific Antibody Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bispecific Antibody Drug Market Size (M USD), 2019-2030
Figure 5. Global Bispecific Antibody Drug Market Size (M USD) (2019-2030)
Figure 6. Global Bispecific Antibody Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bispecific Antibody Drug Market Size by Country (M USD)
Figure 11. Bispecific Antibody Drug Sales Share by Manufacturers in 2023
Figure 12. Global Bispecific Antibody Drug Revenue Share by Manufacturers in 2023
Figure 13. Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bispecific Antibody Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bispecific Antibody Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bispecific Antibody Drug Market Share by Type
Figure 18. Sales Market Share of Bispecific Antibody Drug by Type (2019-2024)
Figure 19. Sales Market Share of Bispecific Antibody Drug by Type in 2023
Figure 20. Market Size Share of Bispecific Antibody Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Bispecific Antibody Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bispecific Antibody Drug Market Share by Application
Figure 24. Global Bispecific Antibody Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Bispecific Antibody Drug Sales Market Share by Application in 2023
Figure 26. Global Bispecific Antibody Drug Market Share by Application (2019-2024)
Figure 27. Global Bispecific Antibody Drug Market Share by Application in 2023
Figure 28. Global Bispecific Antibody Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bispecific Antibody Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Bispecific Antibody Drug Sales Market Share by Country in 2023
Figure 32. U.S. Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Bispecific Antibody Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Bispecific Antibody Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Bispecific Antibody Drug Sales Market Share by Country in 2023
Figure 37. Germany Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Bispecific Antibody Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Bispecific Antibody Drug Sales Market Share by Region in 2023
Figure 44. China Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Bispecific Antibody Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Bispecific Antibody Drug Sales Market Share by Country in 2023
Figure 51. Brazil Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Bispecific Antibody Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Bispecific Antibody Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Bispecific Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Bispecific Antibody Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Bispecific Antibody Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bispecific Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bispecific Antibody Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Bispecific Antibody Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Bispecific Antibody Drug Market Share Forecast by Application (2025-2030)
